Description
Disclaimer:
Retatrutide is sold strictly for in-vitro laboratory research use only. It is not a drug, food additive, cosmetic, or dietary supplement. This material is not approved by the FDA or any regulatory authority for human or veterinary use, and any discussion of clinical application is for scientific context only—not product endorsement.
| Sequence | YA1QGTFTSDYSIL2LDKK4AQA1AFIEYLLEGGPSSGAPPPS3 |
| Molecular Formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Molecular Weight | ~4731.3 Da |
| PubChem CID | 485663353 |
| CAS # | 2381089‑83‑2 |
In laboratory settings, Retatrutide is being studied for its effects on appetite regulation, glycemic control, and energy expenditure. Its unique receptor profile aims to mimic and amplify the body’s natural hormonal signals that govern satiety, insulin sensitivity, and fat metabolism. Early-stage clinical data suggest significant reductions in body weight and improvements in glucose homeostasis in models simulating obesity and type 2 diabetes.
Researchers are particularly interested in Retatrutide’s multi-receptor synergy—how simultaneous activation may lead to greater metabolic effects than single or dual agonist peptides. This makes it a critical subject for the study of advanced therapies targeting complex metabolic disorders.
Reviews
There are no reviews yet.